A narrative review warned that AI tools for diagnosing stone-associated urinary infections show promise but remain limited by retrospective designs and weak external validation. The review’s key point for clinical adoption is that model performance may not hold up across sites without rigorous prospective testing and dataset-independent validation, particularly for heterogeneous patient populations.